|
|
Capacity Development
Page 1 of 2
 - A Kernel for Open Source Drug Discovery in Tropical Diseases
Orti L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, et al. (2009) A Kernel for Open Source Drug Discovery in Tropical Diseases. PLoS Negl Trop Dis 3(4).
- An Ex-Ante and Ex-Post Perspective: Mode of Entry for Emerging Markets (2009)
M. Allarakhia; Chapter Submission: Initiative for Policy Dialogue-Volume on Intellectual Property Rights.
- Bayh-Dole: if we knew then what we know now
S. Boettiger and A. Bennett; Nature Biotechnology 24, 320 - 323 (2006).
- Can Open-Source Drug R&D Repower Pharmaceutical Innovation?
B Munos; Clinical Pharmacology & Therapeutics 87, 534-536 (May 2010).
- Challenges for pharmaceutical industry: new partnerships for sustainable human health
Hunter, J. Phil. Trans. R. Soc. A 13 May 2011 vol. 369 no. 1942 1817-1825.
- Clusters or un-clustered industries? Where inter-firm marketing cooperation matters
Christian Felzensztein, Eli Gimmon, Claudio Aqueveque, (2012), Journal of Business & Industrial Marketing, Vol. 27 Iss: 5 pp. 392 - 402.
- Collaborative Drug Discovery: The Rising Importance of Rare And Neglected Diseases
Ekins S; Collaborative Drug Discovery; November 2010.
- Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration
DA Chokshi, M Parker, DP Kwiatkowski; Bull World Health Organ. 2006 May;84(5):382-7.
- Developing a framework for understanding and enabling open source drug discovery
M. Allarakhia; Expert Opinion on Drug Discovery, 5(8), 2010.
- Ethical Data Release in Genome-Wide Association Studies in Developing Countries
M Parker, SJ Bull, J de Vries, T Agbenyega, OK Doumbo, et al.; PLoS Med 6(11), 2009.
- Evolving Concept of Openness in the Health Commons
M. Allarakhia; Convening Cultural Commons: Conference of the Engelberg Center on Innovation Law & Policy, New York, NY, 2011.
- Facilitating creative partnerships in biopharmaceutical research
Lawrence, S; CQDM, Biotechnology Focus, 2009.
- How Informatics Can Potentiate Precompetitive Open-Source Collaboration to Jump-Start Drug Discovery and Development
Perakslis ED, Van Dam J, Szalma S; Clin Pharma Therap 2010, 87:614-6.
- How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities
T. Senderovitz; Expert Rev. Clin. Pharmacol. 2(6), 585-587 (2009).
- Innovation in Developing Countries to Meet Health Needs: Experiences of Brazil, China, India and South Africa
MIHR report to CIPIH, April 2005.
- Innovative Partnerships for Drug Discovery against Neglected Diseases
Jakobsen PH, Wang M-W, Nwaka S (2011) Innovative Partnerships for Drug Discovery against Neglected Diseases. PLoS Negl Trop Dis 5(9): e1221.
- Intellectual Property Rights and Innovation in South Africa: A Framework
Kaplan D. The Economics of Intellectual Property in Africa, WIPO.
- Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience
So AD, Sampat BN, Rai AK, Cook-Deegan R, Reichman JH, et al. (2008) Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience. PLoS Biol 6(10): e262.
- Is open innovation the way forward for big pharma?
J. Hunter and S. Stephens; Nature Reviews Drug Discovery 9, 87-88 (February 2010).
- Labs: Designing the Future
Lisa Torjman, Manager, SiG@MaRS
1
2
|
|
|
